Schedule 13G ownership disclosure

Cyclacel Pharmaceuticals Inc

Security class unavailable · CUSIP: 23254L405

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,269,326
Percent of class
7.3800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001037389-20-000011
Form type
SC 13G
Filer
Bio Green Med Solution, Inc.
CIK
CIK 1130166
Filed
Feb 12, 2020
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub